Nicholas Robertson
About Nicholas Robertson
Nicholas Robertson serves as the Head of Clinical Operations at Generate:Biomedicines, bringing extensive experience from various roles in clinical operations and research. His background includes positions at notable organizations such as Apellis Pharmaceuticals and BlueRock Therapeutics, along with academic credentials from Boston University School of Medicine and Saint Michael's College.
Current Role at Generate Biomedicines
Nicholas Robertson serves as the Head of Clinical Operations at Generate:Biomedicines. He has held this position since 2023, overseeing clinical operations in Somerville, Massachusetts. His responsibilities include managing clinical trial processes and ensuring compliance with regulatory standards.
Previous Experience in Clinical Operations
Prior to his current role, Nicholas Robertson worked in various capacities within clinical operations. He served as Associate Director of Clinical Operations at BlueRock Therapeutics from 2021 to 2022. He also held positions at Apellis Pharmaceuticals, including Senior Clinical Trial Manager and Associate Director of Clinical Operations, from 2019 to 2021 and 2021 respectively.
Educational Background in Biology and Forensic Science
Nicholas Robertson earned a Bachelor of Science (BS) in Biology from Saint Michael's College, studying from 2005 to 2009. He furthered his education at Boston University School of Medicine, where he obtained a Master of Science (M.S.) in Biomedical Forensic Science from 2009 to 2011.
Early Career at Boston University School of Medicine
Nicholas Robertson began his career as a Research Technician at Boston University School of Medicine, where he worked from 2010 to 2013. This role provided him with foundational experience in research methodologies and laboratory practices.
Experience in Pharmaceutical Industry
Nicholas Robertson has extensive experience in the pharmaceutical industry, having worked at several companies. He was an Associate Scientist II at Enanta Pharmaceuticals from 2013 to 2016 and held various roles at Alkermes, including Senior Clinical Trial Associate and Clinical Trial Associate from 2016 to 2017.